Advanced Medical Isotope (OTCMKTS:RDGL – Get Free Report) and Medallion Financial (NASDAQ:MFIN – Get Free Report) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership.
Volatility and Risk
Advanced Medical Isotope has a beta of -0.77, indicating that its share price is 177% less volatile than the S&P 500. Comparatively, Medallion Financial has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500.
Earnings and Valuation
This table compares Advanced Medical Isotope and Medallion Financial”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Advanced Medical Isotope | $70,000.00 | 492.23 | -$3.07 million | ($0.01) | -6.98 |
| Medallion Financial | $353.31 million | 0.64 | $43.04 million | $1.48 | 6.37 |
Medallion Financial has higher revenue and earnings than Advanced Medical Isotope. Advanced Medical Isotope is trading at a lower price-to-earnings ratio than Medallion Financial, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
40.6% of Medallion Financial shares are owned by institutional investors. 18.5% of Advanced Medical Isotope shares are owned by insiders. Comparatively, 24.6% of Medallion Financial shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
This table compares Advanced Medical Isotope and Medallion Financial’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Advanced Medical Isotope | -4,380.77% | N/A | -138.20% |
| Medallion Financial | 10.35% | 7.73% | 1.35% |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Advanced Medical Isotope and Medallion Financial, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Advanced Medical Isotope | 0 | 0 | 0 | 0 | 0.00 |
| Medallion Financial | 1 | 1 | 1 | 0 | 2.00 |
Medallion Financial has a consensus price target of $12.00, suggesting a potential upside of 27.25%. Given Medallion Financial’s stronger consensus rating and higher possible upside, analysts clearly believe Medallion Financial is more favorable than Advanced Medical Isotope.
Summary
Medallion Financial beats Advanced Medical Isotope on 13 of the 14 factors compared between the two stocks.
About Advanced Medical Isotope
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
About Medallion Financial
Medallion Financial Corp., together with its subsidiaries, operates as a specialty finance company in the United States. It operates in four segments: Recreation Lending, Home Improvement Lending, Commercial Lending, and Taxi Medallion Lending. The company offers loans that finance consumer purchases of recreational vehicles, boats, and other consumer recreational equipment; consumer financing for window, siding, and roof replacement, swimming pool installations, and other home improvement projects; senior and subordinated loans for the purchase of equipment and related assets necessary to open a new business, or purchase or improvement of an existing business; and taxi medallion loans to individuals and small to mid-size businesses. It also provides debt, mezzanine, and equity investment capital to companies in various commercial industries; and raises deposits and conducts other banking activities. Medallion Financial Corp. was incorporated in 1995 and is headquartered in New York City, New York.
Receive News & Ratings for Advanced Medical Isotope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Isotope and related companies with MarketBeat.com's FREE daily email newsletter.
